Literature DB >> 12894233

The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA.

Maret Böhm1, Kirsty Sawicka, Jan Peter Siebrasse, Anne Brehmer-Fastnacht, Reiner Peters, Karl-Heinz Klempnauer.   

Abstract

The Pdcd4 gene has originally been isolated in a search for genes that are activated in cells undergoing apoptosis. Independent of these studies, the Pdcd4 gene has been implicated in the suppression of tumor-promoter-mediated transformation of keratinocytes and as a downstream target of Myb in hematopoietic cells. The Pdcd4 protein has weak homology to the eucaryotic translation initiation factor eIF4G and has been shown to interact with certain translation initiation factors. To explore the molecular function of the Pdcd4 protein, we have studied its subcellular localization. We show that the Pdcd4 protein is a predominantly nuclear protein under normal growth conditions and that it is exported from the nucleus by a leptomycin B-sensitive mechanism upon serum withdrawal. The protein contains two nuclear export signals, one of which is very potent. In addition, we demonstrate that the Pdcd4 protein has RNA-binding activity and that the sequences involved in RNA-binding are located in the amino-terminal part of the protein. Taken together, our data raise the possibility that Pdcd4 is involved in some aspect of nuclear RNA metabolism in addition to its suspected role in protein translation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12894233     DOI: 10.1038/sj.onc.1206710

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

1.  PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis.

Authors:  Matteo Fassan; Marco Pizzi; Luciano Giacomelli; Claudia Mescoli; Kathrin Ludwig; Salvatore Pucciarelli; Massimo Rugge
Journal:  Virchows Arch       Date:  2011-01-29       Impact factor: 4.064

Review 2.  Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue?

Authors:  Matthew R Young; Arti N Santhanam; Noriko Yoshikawa; Nancy H Colburn
Journal:  Mol Interv       Date:  2010-04

3.  Enhanced arginine methylation of programmed cell death 4 protein during nutrient deprivation promotes tumor cell viability.

Authors:  Marta M Fay; James M Clegg; Kimberly A Uchida; Matthew A Powers; Katharine S Ullman
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

4.  Tumor suppressor PDCD4 represses internal ribosome entry site-mediated translation of antiapoptotic proteins and is regulated by S6 kinase 2.

Authors:  Urszula Liwak; Nehal Thakor; Lindsay E Jordan; Rajat Roy; Stephen M Lewis; Olivier E Pardo; Michael Seckl; Martin Holcik
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

5.  A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A.

Authors:  Hsin-Sheng Yang; Myung-Haing Cho; Halina Zakowicz; Glenn Hegamyer; Nahum Sonenberg; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

6.  PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis.

Authors:  Kathrin Ludwig; Matteo Fassan; Claudia Mescoli; Marco Pizzi; Mariangela Balistreri; Laura Albertoni; Salvatore Pucciarelli; Marco Scarpa; Giacomo Carlo Sturniolo; Imerio Angriman; Massimo Rugge
Journal:  Virchows Arch       Date:  2012-12-08       Impact factor: 4.064

7.  Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis.

Authors:  Matteo Fassan; Marco Pizzi; Giorgio Battaglia; Luciano Giacomelli; Paola Parente; Paolo Bocus; Ermanno Ancona; Massimo Rugge
Journal:  J Clin Pathol       Date:  2010-08       Impact factor: 3.411

8.  Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma.

Authors:  Patricia P Reis; Miranda Tomenson; Nilva K Cervigne; Jerry Machado; Igor Jurisica; Melania Pintilie; Mahadeo A Sukhai; Bayardo Perez-Ordonez; Reidar Grénman; Ralph W Gilbert; Patrick J Gullane; Jonathan C Irish; Suzanne Kamel-Reid
Journal:  Mol Cancer       Date:  2010-09-10       Impact factor: 27.401

9.  Programmed cell death 4 mechanism of action: The model to be updated?

Authors:  Polina N Vikhreva; Svetlana V Kalinichenko; Igor V Korobko
Journal:  Cell Cycle       Date:  2017-08-30       Impact factor: 4.534

10.  Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer.

Authors:  N A Wei; Stephanie S Liu; Thomas H Y Leung; Kar F Tam; Xiao Y Liao; Annie N Y Cheung; Karen K L Chan; Hextan Y S Ngan
Journal:  Mol Cancer       Date:  2009-09-03       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.